Regulatory Science and Drug Approval for Alcoholic and Nonalcoholic Steatohepatitis

被引：17
|
作者：
Sanyal, Arun J. [1 ]
Miller, Veronica [2 ]
机构：
[1] VCU Sch Med, Dept Med, MCV Box 980341, Richmond, VA 23298 USA
[2] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 08期
关键词：
Alcoholic Hepatitis; Nonalcoholic Steatohepatitis; Regulatory Science; Drug Approval; Clinical Trials; End Points; Trial Design; Drug Development; RISK-FACTORS; HEPATITIS; OUTCOMES; CHALLENGES; MELD;
D O I：
10.1053/j.gastro.2016.02.044
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1723 / 1727
页数：5
相关论文
共 50 条
  • [31] Trials and Tribulations in Drug Development for Nonalcoholic Steatohepatitis
    Sanyal, Arun J.
    Chalasani, Naga
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (12) : 2104 - 2105
  • [32] Challenges and opportunities in drug development for nonalcoholic steatohepatitis
    Ocker, Matthias
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 870
  • [33] Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update
    Chew, Nicholas W. S.
    Ng, Cheng Han
    Truong, Emily
    Noureddin, Mazen
    Kowdley, Kris, V
    SEMINARS IN LIVER DISEASE, 2022, 42 (03) : 379 - 400
  • [34] Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
    Siddiqui, Mohammad Shadab
    Harrison, Stephen A.
    Abdelmalek, Manal F.
    Anstee, Quentin M.
    Bedossa, Pierre
    Castera, Laurent
    Dimick-Santos, Lara
    Friedman, Scott L.
    Greene, Katherine
    Kleiner, David E.
    Megnien, Sophie
    Neuschwander-Tetri, Brent A.
    Ratziu, Vlad
    Schabel, Elmer
    Miller, Veronica
    Sanyal, Arun J.
    HEPATOLOGY, 2018, 67 (05) : 2001 - 2012
  • [35] Ductular reaction in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
    Gavrilyuk, O. M.
    PATHOLOGIA, 2014, (01): : 41 - 44
  • [36] Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Tilg, Herbert
    Moschen, Alexander R.
    Szabo, Gyongyi
    HEPATOLOGY, 2016, 64 (03) : 955 - 965
  • [37] Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis?
    Sakhuja, Puja
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (44) : 16474 - 16479
  • [38] Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis?
    Puja Sakhuja
    World Journal of Gastroenterology, 2014, (44) : 16474 - 16479
  • [39] Serum Cytokeratin 18 and Adipocytokines in Alcoholic Hepatitis Versus Nonalcoholic Steatohepatitis
    Zewdu, Manny C.
    Henry, LaTasha
    Falkner, Keith C.
    McClain, Craig J.
    Cave, Matthew C.
    GASTROENTEROLOGY, 2010, 138 (05) : S804 - S804
  • [40] Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver Disease
    Bhanji, Rahima A.
    Narayanan, Praveena
    Moynagh, Michael R.
    Takahashi, Naoki
    Angirekula, Mounika
    Kennedy, Cassie C.
    Mara, Kristin C.
    Dierkhising, Ross A.
    Watt, Kymberly D.
    LIVER TRANSPLANTATION, 2019, 25 (01) : 14 - 24
12345